Gyre Therapeutics, Inc. (GYRE)

NASDAQ: GYRE · Real-Time Price · USD

9.11

-0.37 (-3.90%)

May 9, 2025, 11:08 AM - Market open

Gyre Therapeutics Employees

Gyre Therapeutics had 579 employees as of December 31, 2024. The number of employees decreased by 14 or -2.36% compared to the previous year.

Employees

579

Change (1Y)

-14

Growth (1Y)

-2.36%

Revenue / Employee

$173,822

Profits / Employee

$12,523

Market Cap

854.00M

Employees Chart

Employees History

Date	Employees	Change	Growth
Dec 31, 2024	579	-14	-2.36%
Dec 31, 2023	593	-	-

Related Stocks

Company Name	Employees
UnitedHealth Group	400,000
Johnson & Johnson	138,100
Thermo Fisher Scientific	125,000
Abbott Laboratories	114,000
AstraZeneca	94,300
Novo Nordisk	77,349
Novartis AG	75,883
Merck & Co.	75,000

Employee Rankings

GYRE News

5 hours ago - Gyre Therapeutics Reports First Quarter 2025 Financial Results and Provides Business Update - GlobeNewsWire
5 weeks ago - Gyre Therapeutics Announces NMPA Approval for Clinical Trial Evaluating Pirfenidone Capsules in Oncology-Related Pulmonary Complications - GlobeNewsWire
6 weeks ago - Gyre Therapeutics Announces Publication of Protocol for Phase 3 Trial Evaluating F351 for CHB-Associated Liver Fibrosis in Journal of Clinical and Translational Hepatology - GlobeNewsWire
7 weeks ago - Gyre Therapeutics Reports Fourth Quarter and Full Year 2024 Financial Results and Provides Business Update - GlobeNewsWire
6 months ago - Gyre Therapeutics Reports Third Quarter 2024 and Year-To-Date Financial Results and Provides Business Update - GlobeNewsWire
7 months ago - Gyre Therapeutics Announces Last Patient Completed Pivotal Phase 3 Trial Evaluating F351 for CHB-Associated Liver Fibrosis - GlobeNewsWire
7 months ago - Gyre Therapeutics to Present at 8th Annual H.C. Wainwright MASH Investor Conference - GlobeNewsWire
9 months ago - Gyre Therapeutics Reports Second Quarter 2024 and Year-To-Date Financial Results and Provides Business Update - GlobeNewsWire